CCM Investment Advisers’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $220K | Sell |
626
-5
| -0.8% | -$1.78K | 0.02% | 84 |
|
|
2025
Q4 | $207K | Buy |
+631
| New | +$200K | 0.02% | 84 |
|
|
2024
Q4 | – | Sell |
-721
| Closed | -$232K | – | 76 |
|
|
2024
Q3 | $232K | Buy |
721
+20
| +3% | +$6.54K | 0.03% | 72 |
|
|
2024
Q2 | $219K | Buy |
+701
| New | +$206K | 0.03% | 73 |
|
|
2022
Q1 | – | Sell |
-930
| Closed | -$209K | – | 68 |
|
|
2021
Q4 | $209K | Buy |
+930
| New | +$196K | 0.03% | 68 |
|
|
2021
Q3 | – | Sell |
-930
| Closed | -$226K | – | 68 |
|
|
2021
Q2 | $226K | Hold |
930
| – | – | 0.03% | 68 |
|
|
2021
Q1 | $231K | Sell |
930
-75
| -7% | -$17.9K | 0.03% | 66 |
|
|
2020
Q4 | $231K | Sell |
1,005
-15
| -1% | -$3.46K | 0.03% | 65 |
|
|
2020
Q3 | $259K | Hold |
1,020
| – | – | 0.04% | 64 |
|
|
2020
Q2 | $240K | Sell |
1,020
-175
| -15% | -$39.9K | 0.04% | 60 |
|
|
2020
Q1 | $242K | Sell |
1,195
-370
| -24% | -$80.8K | 0.05% | 62 |
|
|
2019
Q4 | $377K | Sell |
1,565
-74
| -5% | -$16.3K | 0.06% | 56 |
|
|
2019
Q3 | $317K | Sell |
1,639
-246
| -13% | -$47.2K | 0.05% | 58 |
|
|
2019
Q2 | $347K | Sell |
1,885
-3,115
| -62% | -$558K | 0.06% | 61 |
|
|
2019
Q1 | $949K | Sell |
5,000
-58,439
| -92% | -$11.2M | 0.16% | 55 |
|
|
2018
Q4 | $12.3M | Buy |
63,439
+6,656
| +12% | +$1.3M | 2.46% | 11 |
|
|
2018
Q3 | $11.8M | Sell |
56,783
-1,168
| -2% | -$230K | 2.17% | 13 |
|
|
2018
Q2 | $10.7M | Buy |
57,951
+1,744
| +3% | +$308K | 2.04% | 17 |
|
|
2018
Q1 | $9.58M | Buy |
56,207
+1,119
| +2% | +$205K | 1.87% | 24 |
|
|
2017
Q4 | $9.58M | Sell |
55,088
-1,004
| -2% | -$178K | 1.85% | 29 |
|
|
2017
Q3 | $10.5M | Sell |
56,092
-1,901
| -3% | -$337K | 2.01% | 15 |
|
|
2017
Q2 | $9.99M | Sell |
57,993
-444
| -0.8% | -$72.2K | 1.95% | 20 |
|
|
2017
Q1 | $9.59M | Sell |
58,437
-883
| -1% | -$147K | 1.91% | 16 |
|
|
2016
Q4 | $8.67M | Buy |
59,320
+982
| +2% | +$148K | 1.83% | 22 |
|
|
2016
Q3 | $9.73M | Sell |
58,338
-68,395
| -54% | -$11.6M | 2.06% | 16 |
|
|
2016
Q2 | $19.3M | Sell |
126,733
-10,211
| -7% | -$1.59M | 1.8% | 17 |
|
|
2016
Q1 | $20.5M | Sell |
136,944
-3,606
| -3% | -$536K | 1.92% | 18 |
|
|
2015
Q4 | $22.8M | Sell |
140,550
-3,779
| -3% | -$594K | 2.14% | 19 |
|
|
2015
Q3 | $20M | Buy |
144,329
+11,442
| +9% | +$1.8M | 1.99% | 19 |
|
|
2015
Q2 | $20.4M | Buy |
132,887
+11,957
| +10% | +$1.92M | 1.88% | 28 |
|
|
2015
Q1 | $19.3M | Sell |
120,930
-6,751
| -5% | -$1.06M | 1.89% | 21 |
|
|
2014
Q4 | $20.3M | Sell |
127,681
-28,792
| -18% | -$4.49M | 1.85% | 23 |
|
|
2014
Q3 | $22M | Sell |
156,473
-12,640
| -7% | -$1.65M | 1.96% | 21 |
|
|
2014
Q2 | $20M | Buy |
169,113
+2,158
| +1% | +$250K | 1.83% | 27 |
|
|
2014
Q1 | $20.6M | Buy |
166,955
+3,433
| +2% | +$416K | 2.04% | 18 |
|
|
2013
Q4 | $18.7M | Sell |
163,522
-492
| -0.3% | -$56K | 1.74% | 24 |
|
|
2013
Q3 | $18.4M | Buy |
164,014
+12,887
| +9% | +$1.4M | 1.82% | 18 |
|
|
2013
Q2 | $14.9M | Buy |
+151,127
| New | +$15.7M | 1.53% | 28 |
|
Other funds holding AMGN
VCM
VPM
CCM Investment Advisers's AMGN Position: Q1 2026 in Review
CCM Investment Advisers reduced its Amgen (AMGN) stake by 0.79% in Q1 2026, selling an estimated $1.78K and leaving 626 shares worth $220K. The position accounts for 0.02% of the portfolio, ranked #84.
CCM Investment Advisers first reported a position in AMGN in Q2 2013 and has held it in 38 quarters since. The position peaked at $22.8M in Q4 2015. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- CCM Investment Advisers held 626 shares of Amgen worth $220K as of Q1 2026.
- CCM Investment Advisers sold 5 Amgen shares in Q1 2026, an estimated $1.78K.
- Amgen made up 0.02% of CCM Investment Advisers's portfolio in Q1 2026, its #84 holding.
- CCM Investment Advisers first reported a position in Amgen in Q2 2013 and has held it in 38 quarters since.
- CCM Investment Advisers's Amgen position peaked at $22.8M in Q4 2015.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on CCM Investment Advisers's 13F filing for Q1 2026, filed 20 May 2026.